Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 11/20 | 0.79 |
| ▸ | MMP9 | P14780 | 10/20 | 0.79 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.74 |
| ▸ | MMP3 | P08254 | 2/20 | 0.70 |
| ▸ | MMP13 | P45452 | 2/20 | 0.70 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.70 |
| ▸ | MMP1 | P03956 | 1/20 | 0.70 |
| ▸ | MMP7 | P09237 | 1/20 | 0.70 |
| ▸ | CTSL | P07711 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL697476 | 1.00 | MMP2 (0.79) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| SCHEMBL1203540 | 1.00 | MMP2 (0.79) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL11133046 | 0.99 | MMP2 (0.77) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL3839410 | 0.99 | MMP2 (0.77) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28872216 | 0.97 | MMP2 (0.75) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| Chloromethane SCHEMBL7649372 | 0.97 | MMP2 (0.75) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| SCHEMBL3856155 | 0.96 | MMP2 (0.73) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| SCHEMBL561565 | 0.95 | MMP2 (0.71) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| SCHEMBL433897 | 0.95 | MMP2 (0.71) | MMP2MMP9ADAMTS4TDP1ALDH1A1 | |
| SCHEMBL8063645 | 0.94 | TDP1 (0.78) | MMP2MMP9ADAMTS4TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4330229-B1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2025-12-17 | — | — | EP | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| US-20240228437-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-07-11 | — | — | US | claimed |
| EP-4330229-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2024-03-06 | — | — | EP | claimed |
| CN-117529470-A | Method for producing pyrrolidine compounds | 武田药品工业株式会社 | 2024-02-06 | — | — | CN | claimed |
| CN-116650519-A | Stabilized Hyaluronic Acid | 克罗马药品有限责任公司 | 2023-08-29 | — | — | CN | claimed |
| CN-115248272-B | Method for detecting alpha-ketoglutaric acid and chiral 2-hydroxyglutaric acid | 深圳深检集团医学检验实验室 | 2023-04-18 | — | — | CN | claimed |
| CN-115248272-A | Method for detecting alpha-ketoglutaric acid and chiral 2-hydroxyglutaric acid | 深检集团(深圳)医学检验实验室 | 2022-10-28 | — | — | CN | claimed |
| US-20190135810-A1 | PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES | PTC THERAPEUTICS INC (US) | 2019-05-09 | — | — | US | claimed |
| EP-1457487-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE CIS-PIPERIDINE DERIVATIVES | Toray Fine Chemicals Co., Ltd. (JP) | 2004-09-15 | — | — | EP | claimed |
| US-20040171836-A1 | Method for producing optical-active cis-piperidine derivatives | TORAY FINE CHEMICALS CO., LTD., A CORPORATION OF JAPAN, (JP) | 2004-09-02 | — | — | US | claimed |
| EP-1177168-A4 | CASPASE INHIBITORS AND THE USE THEREOF | CYTOVIA INC (US) | 2003-06-25 | — | — | EP | claimed |
| JP-2002541237-A | — | — | 2002-12-03 | — | — | JP | claimed |
| EP-1177168-A1 | CASPASE INHIBITORS AND THE USE THEREOF | Cytovia, Inc. (US) | 2002-02-06 | — | — | EP | claimed |
| WO-2000061542-A1 | CASPASE INHIBITORS AND THE USE THEREOF | CYTOVIA, INC. (US) | 2000-10-19 | — | — | WO | claimed |
| US-5688965-A | BACTERICIDES | CHEIL FOODS & CHEMICALS, INC. (KR) | 1997-11-18 | — | — | US | claimed |
| EP-0212010-A1 | Color developers for pressure-sensitive or heat-sensitive recording papers | THE STANDARD REGISTER COMPANY (US) | 1987-03-04 | — | — | EP | claimed |
| US-4623391-A | COMPOUNDS HAVING ELECTRON-WITH DRAWING GROUPS WITHIN FIVE ATOMS OF A SULFANAMIDE | THE STANDARD REGISTER COMPANY (US) | 1986-11-18 | — | — | US | claimed |
| US-4531139-A | Color developers for pressure-sensitive or heat-sensitive recording papers | THE STANDARD REGISTER COMPANY (US) | 1985-07-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171836-A1 | Method for producing optical-active cis-piperidine derivatives | TYR, DDC, TARBP1 | MMP2 1206/4885MMP9 1373/4885ADAMTS4 2548/4885 |
| US-20240228437-A1 | METHOD FOR PRODUCING PYRROLIDINE COMPOUND | PAH, SPR, IL4I1 | MMP2 2034/4885MMP9 2916/4885ADAMTS4 4409/4885 |
| US-20190135810-A1 | PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES | TPH1, TPH2, HTR1B | MMP2 3524/4885MMP9 3464/4885ADAMTS4 3638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.